Latest News

Telemedicine: Three fraud and abuse triggers


 

3. Free patient technology. The Civil Monetary Penalties Law is another fraud and abuse statute that can come into play in the telemedicine setting. Under this law, health professionals cannot knowingly solicit or receive remuneration for a patient referral nor can they induce patients to visit them via incentives such as free products. In the telemedicine context, the law can be triggered when practices offer patients free remote monitoring devices or apps that help track medical data.

“Hospitals and groups have very legitimate reasons to want to provide their patients with these types of tools for free,” Ms. Mazur said. “But anytime a health professional who is billing Medicare for services provides some to a patient for free, there’s a concern that you’re giving that service or product because you’re trying to induce them to come to you for care.”

The right parameters around free telemedicine tools can make all the difference, she said. For example, it’s important that practices do not market the free or discounted product to patients, according to Ms. Mazur. Also, make clear that the free products do not increase profits for the practice and that the offerings do not raise federal health care billings. Another way to go about it is to include the practice of providing a free telemedicine product or device under the scope of their charity policy by including language outlining when free or discounted products or services can be provided to underinsured patients, Ms. Mazur said.

Another good idea is for practices to integrate telemedicine into their corporate compliance programs. All health care entities are encouraged to have a corporate compliance program that outlines policies, training protocols, and standards of conduct to prevent, identify, and mitigate fraud and abuse.

Practices “need to make sure their existing compliance programs, including policies and procedures, take into account the nuances that are implicated by telemedicine,” Ms. Mazur said.

Pages

Recommended Reading

Doctors decry inaction on physician-focused APMs
Journal of Clinical Outcomes Management
Broad genomic testing of NSCLC in community oncology disappoints
Journal of Clinical Outcomes Management
CMS pushes ACOs to take on more risk
Journal of Clinical Outcomes Management
Docs push back on step therapy in Medicare Advantage
Journal of Clinical Outcomes Management
Having prescription drug coverage is associated with improved myeloma outcomes
Journal of Clinical Outcomes Management
Feds aim to streamline gene therapy oversight
Journal of Clinical Outcomes Management
CMS finalizes CAR T-cell therapy inpatient payments
Journal of Clinical Outcomes Management
Feds take baseline on EHR interoperability
Journal of Clinical Outcomes Management
Study examines the world of alcohol use
Journal of Clinical Outcomes Management
Tuition-free med school touches off multimillion-dollar debate
Journal of Clinical Outcomes Management